VIE Gross Margin

The Gross Margin of Viela Bio Inc (VIE) is 82.49%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

VIE Gross Margin - Historical Value

Date	Value
2020-12-31	82.49%

VIE Gross Margin - Peers Comparison

Ticker	Name	Value
950200.KQ	Psomagen Inc	23.13%
IMCR	Immunocore Holdings PLC	99.12%
950160.KQ	Kolon TissueGene Inc	11.72%
FOLD	Amicus Therapeutics Inc	89.98%
GBT	Global Blood Therapeutics Inc	98.30%
GILD	Gilead Sciences Inc	78.26%
MRNA	Moderna Inc	70.06%
RCUS	Arcus Biosciences Inc	7775.20%
SWTX	SpringWorks Therapeutics Inc	93.45%
ABBV	Abbvie Inc	69.99%
ADCT	ADC Therapeutics SA	91.60%
ALXO	ALX Oncology Holdings Inc	9.32%
BCAB	Bioatla Inc	7775.20%
CCXI	ChemoCentryx Inc	99.06%
GBIO	Generation Bio Co	7775.20%
LEGN	Legend Biotech Corp	62.60%
NRIX	Nurix Therapeutics Inc	7775.20%
RUBY	Rubius Therapeutics Inc	7775.20%
INO	Inovio Pharmaceuticals Inc	60.13%
MYOV	Myovant Sciences Ltd	77.68%
RVMD	Revolution Medicines Inc	7775.20%
950220.KQ	Neoimmunetech Inc	7775.20%
KYMR	Kymera Therapeutics Inc	7775.20%
LGND	Ligand Pharmaceuticals Inc	93.37%
MCRB	Seres Therapeutics Inc	7775.20%
VRTX	Vertex Pharmaceuticals Inc	86.11%
FGEN	FibroGen Inc	47.47%
PRLD	Prelude Therapeutics Inc	7775.20%
REGN	Regeneron Pharmaceuticals Inc	87.01%
AMGN	Amgen Inc	61.53%
CGEM	Cullinan Oncology Inc	7775.20%
RLAY	Relay Therapeutics Inc	7775.20%
AMTI	Applied Molecular Transport Inc.	7775.20%
DCPH	Deciphera Pharmaceuticals Inc	97.72%
IGMS	IGM Biosciences Inc	7775.20%